Besides distinct effects on numerous ECM components, extracellular S100A1 diminished the expression of collagens, inhibited the expression of the myofibroblast marker and inducer SMA and CTGF, respectively, and left CF proliferation unaffected. The gene discussed is S100A1; the disease is cystic fibrosis.